Laurus Labs Ltd.

BSE: 540222 | NSE: LAURUSLABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE947Q01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Laurus Labs Lt Laurus Labs Ltd. | BSE 1083.80 -1.05 (-0.10%) | NSE 1083.40 -1.40 (-0.13%) | Trade | Add

BSE Live

Dec 26, 10:45

1083.80 -1.05 (-0.10%)

Volume

AVERAGE VOLUME

5-Day

43,667

10-Day

87,748

30-Day

73,428

23,210

NSE Live

Dec 26, 10:45

1083.40 -1.40 (-0.13%)

Volume

AVERAGE VOLUME

5-Day

1,602,703

10-Day

1,320,189

30-Day

1,517,257

299,610

Financials

Print/Copy to Excel : Go

Profit & Loss account of Laurus Labs (in Rs. Cr.)	Mar 15
	12 mths
INCOME
Revenue From Operations [Gross]	1,325.64
Less: Excise/Sevice Tax/Other Levies	11.33
Revenue From Operations [Net]	1,314.30
Total Operating Revenues	1,326.59
Other Income	34.07
Total Revenue	1,360.66
EXPENSES
Cost Of Materials Consumed	906.63
Purchase Of Stock-In Trade	6.19
Operating And Direct Expenses	123.24
Changes In Inventories Of FGWIP And Stock In Trade	-84.45
Employee Benefit Expenses	132.82
Finance Costs	106.16
Depreciation And Amortisation Expenses	61.53
Other Expenses	41.92
Total Expenses	1,294.02
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	66.64
Exceptional Items	0.00
Profit/Loss Before Tax	66.64
Tax Expenses-Continued Operations
Current Tax	16.66
Less: MAT Credit Entitlement	16.66
Deferred Tax	-1.53
Other Direct Taxes	0.00
Total Tax Expenses	-1.53
Profit/Loss After Tax And Before ExtraOrdinary Items	68.17
Profit/Loss From Continuing Operations	68.17
Profit/Loss For The Period	68.17
Minority Interest	0.00
Consolidated Profit/Loss After MI And Associates	68.42
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	44.00
Diluted EPS (Rs.)	31.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00
Tax On Dividend	0.00